Please enable JavaScript to continue using this application.

Compare $CBUS vs $UNCY | Chartloom

Compare

$CBUS vs $UNCY

Cibus Inc · Unicycive Therapeutics Inc

CBUS

Cibus Inc

UNCY

Unicycive Therapeutics Inc

Compare $CBUS vs $UNCY

Comparing Cibus Inc and Unicycive Therapeutics Inc

CBUSCibus Inc

UNCYUnicycive Therapeutics Inc

CBUSCibus Inc

Market cap

$118M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.82x

Rev growth (TTM)

-10.3%

YTD performance

-17.6%

52W performance

5.4%

FCF yield

-39.2%

UNCYUnicycive Therapeutics Inc

Market cap

$110M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.31x

Rev growth (TTM)

—

YTD performance

-29.1%

52W performance

-13.8%

FCF yield

-25.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBUS

UNCY

Detailed metrics comparison

CBUS

Cibus Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

CBUS$118M

UNCY$110M

Enterprise Value

CBUS$352M

UNCY$66M

Price

CBUS$1.55

UNCY$4.11

P/E Ratio

CBUSN/A

UNCYN/A

P/S Ratio

CBUS27.22x

UNCY31.15x

EV/Sales

CBUS81.04x

UNCY0.00x

EV/EBITDA

CBUS0.00x

UNCY0.00x

P/B Ratio

CBUS8.83x

UNCY2.21x

P/FCF Ratio

CBUSN/A

UNCYN/A

EV/FCF

CBUS-7.59x

UNCY-2.35x

PEG Ratio

CBUSN/A

UNCYN/A

Forward P/E (NTM)

CBUSN/A

UNCYN/A

Forward P/S (NTM)

CBUS12.82x

UNCY0.31x

Revenue (TTM)

CBUS$4M

UNCY$0

Revenue Growth (YoY)

CBUS-10.3%

UNCYN/A

Forward Rev Growth

CBUS139.3%

UNCY37378.0%

Gross Margin (TTM)

CBUS100.0%

UNCY0.0%

Operating Margin (TTM)

CBUS0.0%

UNCY0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

UNCY0.0%

Net Margin (TTM)

CBUS-2258.9%

UNCY0.0%

FCF Margin (TTM)

CBUS-1067.5%

UNCYN/A

Net Income (TTM)

CBUS$-98M

UNCY$-35M

FCF (TTM)

CBUS$-46M

UNCY$-28M

EPS (TTM)

CBUS-$1.28

UNCY-$1.31

ROE (TTM)

CBUS-32060.0%

UNCY-8881.0%

ROA (TTM)

CBUS-3086.0%

UNCY-5966.0%

ROIC (TTM)

CBUS-3627.0%

UNCY-8881.0%

Cash

CBUS$20M

UNCY$44M

Debt

CBUS$254M

UNCY$0

Net Cash/Debt

CBUS$-234M

UNCY$44M

Current Ratio (TTM)

CBUS1.62x

UNCY3.81x

Quick Ratio (TTM)

CBUS1.47x

UNCY3.28x

Debt/Equity (TTM)

CBUS17.19x

UNCY0.00x

Debt/Assets (TTM)

CBUS0.0%

UNCY0.0%

Interest Coverage (TTM)

CBUSN/A

UNCYN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

UNCY0.00x

Beta

CBUS1.70

UNCY1.78

52W Performance

CBUS5.4%

UNCY-13.8%

YTD Performance

CBUS-17.6%

UNCY-29.1%

% from 52W High

CBUS-63.0%

UNCY-53.0%

% from 52W Low

CBUS42.2%

UNCY4.6%

Asset Turnover (TTM)

CBUS0.01x

UNCY0.05x

FCF Yield (TTM)

CBUS-39.2%

UNCY-25.4%

Earnings Yield (TTM)

CBUS-83.0%

UNCY-32.1%

Dividend Yield (TTM)

CBUSN/A

UNCYN/A

Rule of 40

CBUS-1,077.8

UNCY0.0

EV/GP/RG

CBUS0.72

UNCYN/A

Ticker research

View CBUS research View UNCY research

Metric	CBUS Cibus Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$118M	$110M
Enterprise Value	$352M	$66M
Price	$1.55	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	31.15x
EV/Sales	81.04x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	0.31x
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	N/A
Forward Rev Growth	139.3%	37378.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-35M
FCF (TTM)	$-46M	$-28M
EPS (TTM)	-$1.28	-$1.31
ROE (TTM)	-32060.0%	-8881.0%
ROA (TTM)	-3086.0%	-5966.0%
ROIC (TTM)	-3627.0%	-8881.0%
Financial Health
Cash	$20M	$44M
Debt	$254M	$0
Net Cash/Debt	$-234M	$44M
Current Ratio (TTM)	1.62x	3.81x
Quick Ratio (TTM)	1.47x	3.28x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.78
52W Performance	5.4%	-13.8%
YTD Performance	-17.6%	-29.1%
% from 52W High	-63.0%	-53.0%
% from 52W Low	42.2%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-39.2%	-25.4%
Earnings Yield (TTM)	-83.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	0.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View UNCY research

Valuation

P/S Ratio

CBUS

27.22x

UNCY

31.15x

EV/FCF

CBUS

-7.59x

UNCY

-2.35x

Growth & revenue

Revenue Growth TTM

CBUS

-10.3%

Forward Revenue Growth

UNCY

37378.0%

CBUS

139.3%

Profitability & performance

Gross Margin

CBUS

100.0%

UNCY

0.0%

ROE

UNCY

-8881.0%

CBUS

-32060.0%

FCF Yield %

UNCY

-25.4%

CBUS

-39.2%

52-Week Performance

CBUS

5.4%

UNCY

-13.8%

Detailed metrics comparison

CBUS

Cibus Inc

UNCY

Unicycive Therapeutics Inc

Market Cap

CBUS$118M

UNCY$110M

Enterprise Value

CBUS$352M

UNCY$66M

Price

CBUS$1.55

UNCY$4.11

P/E Ratio

CBUSN/A

UNCYN/A

P/S Ratio

CBUS27.22x

UNCY31.15x

EV/Sales

CBUS81.04x

UNCY0.00x

EV/EBITDA

CBUS0.00x

UNCY0.00x

P/B Ratio

CBUS8.83x

UNCY2.21x

P/FCF Ratio

CBUSN/A

UNCYN/A

EV/FCF

CBUS-7.59x

UNCY-2.35x

PEG Ratio

CBUSN/A

UNCYN/A

Forward P/E (NTM)

CBUSN/A

UNCYN/A

Forward P/S (NTM)

CBUS12.82x

UNCY0.31x

Revenue (TTM)

CBUS$4M

UNCY$0

Revenue Growth (YoY)

CBUS-10.3%

UNCYN/A

Forward Rev Growth

CBUS139.3%

UNCY37378.0%

Gross Margin (TTM)

CBUS100.0%

UNCY0.0%

Operating Margin (TTM)

CBUS0.0%

UNCY0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

UNCY0.0%

Net Margin (TTM)

CBUS-2258.9%

UNCY0.0%

FCF Margin (TTM)

CBUS-1067.5%

UNCYN/A

Net Income (TTM)

CBUS$-98M

UNCY$-35M

FCF (TTM)

CBUS$-46M

UNCY$-28M

EPS (TTM)

CBUS-$1.28

UNCY-$1.31

ROE (TTM)

CBUS-32060.0%

UNCY-8881.0%

ROA (TTM)

CBUS-3086.0%

UNCY-5966.0%

ROIC (TTM)

CBUS-3627.0%

UNCY-8881.0%

Cash

CBUS$20M

UNCY$44M

Debt

CBUS$254M

UNCY$0

Net Cash/Debt

CBUS$-234M

UNCY$44M

Current Ratio (TTM)

CBUS1.62x

UNCY3.81x

Quick Ratio (TTM)

CBUS1.47x

UNCY3.28x

Debt/Equity (TTM)

CBUS17.19x

UNCY0.00x

Debt/Assets (TTM)

CBUS0.0%

UNCY0.0%

Interest Coverage (TTM)

CBUSN/A

UNCYN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

UNCY0.00x

Beta

CBUS1.70

UNCY1.78

52W Performance

CBUS5.4%

UNCY-13.8%

YTD Performance

CBUS-17.6%

UNCY-29.1%

% from 52W High

CBUS-63.0%

UNCY-53.0%

% from 52W Low

CBUS42.2%

UNCY4.6%

Asset Turnover (TTM)

CBUS0.01x

UNCY0.05x

FCF Yield (TTM)

CBUS-39.2%

UNCY-25.4%

Earnings Yield (TTM)

CBUS-83.0%

UNCY-32.1%

Dividend Yield (TTM)

CBUSN/A

UNCYN/A

Rule of 40

CBUS-1,077.8

UNCY0.0

EV/GP/RG

CBUS0.72

UNCYN/A

Ticker research

View CBUS research View UNCY research

Metric	CBUS Cibus Inc	UNCY Unicycive Therapeutics Inc
Market & Valuation
Market Cap	$118M	$110M
Enterprise Value	$352M	$66M
Price	$1.55	$4.11
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	31.15x
EV/Sales	81.04x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-2.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	0.31x
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	N/A
Forward Rev Growth	139.3%	37378.0%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-35M
FCF (TTM)	$-46M	$-28M
EPS (TTM)	-$1.28	-$1.31
ROE (TTM)	-32060.0%	-8881.0%
ROA (TTM)	-3086.0%	-5966.0%
ROIC (TTM)	-3627.0%	-8881.0%
Financial Health
Cash	$20M	$44M
Debt	$254M	$0
Net Cash/Debt	$-234M	$44M
Current Ratio (TTM)	1.62x	3.81x
Quick Ratio (TTM)	1.47x	3.28x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.78
52W Performance	5.4%	-13.8%
YTD Performance	-17.6%	-29.1%
% from 52W High	-63.0%	-53.0%
% from 52W Low	42.2%	4.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.05x
FCF Yield (TTM)	-39.2%	-25.4%
Earnings Yield (TTM)	-83.0%	-32.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	0.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View UNCY research